Rare diseases
Investigational molecules
Locations
An Der Goldgrube 12, Oberstadt, 55131 Mainz, Germany
BioNTech SE focuses on advanced non-small cell lung cancer and small-cell lung cancer, including first-line, relapsed, and metastatic settings. Its trials also address broader advanced lung cancer populations and treatment-resistant disease.
Research in this area includes combination immunotherapy approaches and regimens paired with chemotherapy for patients with advanced thoracic malignancies.
BioNTech SE runs clinical trials in conditions such as Squamous cell carcinoma of lung, Non-small cell lung cancer, Non-small cell lung cancer stage III, Non-small cell lung cancer stage IV, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
BelgiumStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
BelgiumA study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
FranceA study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer
GermanyA Study Testing BNT329 Safety and Effectiveness in Patients With Advanced Solid Tumors That Express the CA19-9 Tumor Marker
GermanyA Study of BNT323 and BNT327 for Patients with Advanced Breast Cancer to Test Safety and Effectiveness
FranceA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
AustriaStudy of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments
BelgiumPhase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer
BelgiumStudy on the Safety and Effectiveness of mFOLFIRINOX with or without BNT321 for Patients with Resected Pancreatic Cancer
DenmarkA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
